CN Stock MarketDetailed Quotes

300006 Chongqing Lummy Pharmaceutical

Watchlist
  • 5.55
  • +0.44+8.61%
Trading Dec 2 10:54 CST
5.86BMarket Cap308.33P/E (TTM)

Chongqing Lummy Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Specialty category191.18M50.08%
Large infusion class66.75M17.49%
Anti-infective class54.93M14.39%
Other varieties54.5M14.28%
Other business9.25M2.42%
Drug sales service5.14M1.35%
View all
Industry Currency:CNY
2023/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing739.21M82.54%
Pharmaceutical circulation119.58M13.35%
Other business21.34M2.38%
Other15.46M1.73%
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
East China region91.83M24.05%
Central China89.55M23.46%
Southwest area71.58M18.75%
South China52.53M13.76%
North China46.76M12.25%
Northeast area18.48M4.84%
Northwest region11.01M2.89%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data